Treatment for arteriosclerosis obliterans complicated with acute thrombosis of lower extremity
10.3760/cma.j.cn113855-20190716-00393
- VernacularTitle:下肢动脉硬化性闭塞症合并急性血栓形成的治疗
- Author:
Hao LIU
1
;
Bin CHEN
;
Junhao JIANG
;
Yun SHI
;
Tao MA
;
Daqiao GUO
;
Xin XU
;
Jue YANG
;
Zhenyu SHI
;
Ting ZHU
;
Gang FANG
;
Chao FANG
;
Xiaolang JIANG
;
Zhihui DONG
;
Weiguo FU
Author Information
1. 复旦大学附属中山医院血管外科，上海 200030
- From:
Chinese Journal of General Surgery
2020;35(7):540-544
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To discuss the clinical treatment for arteriosclerosis obliterans combined with acute thrombosis (ASOCAT) of lower extremities.Methods:The treatment methods and results of 30 patients with ASOCAT admitted to our center from Jan 2009 to May 2019 were retrospectively analyzed.Results:The course of acute thrombosis in 30 patients was (9.5±5.2) days, and the average course of ASO was (2.1±1.4) years. Among 30 patients, 13 patients had aortoiliac occlusion (type Ⅰ), and 17 patients had femoropopliteal lesion (type Ⅱ). Twenty-eight patients underwent endovascular treatment, 1 had hybrid operation, and 1 was given aorto-bilateral femoral bypass. One patient died perioperatively. 24 patients were followed up for (16.3±16.1) months. One died during follow-up.Two patients underwent above-knee amputation within 6 months. Two patients had distal superficial femoral artery reocclusion within 12 months. The restenosis/reocclusion rates within 12 months of type Ⅰ and Ⅱ patients were 12.5% and 21.4%, respectively. The 6/12-month amputation-free survival rates for type Ⅰ and type Ⅱ were 87.5%/87.5% and 92.8%/85.7%, respectively.Conclusion:Reasonable and active use of open surgery, endovascular treatment or hybrid operation could achieve acceptable outcomes in patients with ASOCAT.
